Jim Van Meerten's  Instablog

Jim Van Meerten
Send Message
Jim Van Meerten is an advisor to Marketocracy Capital Management and writes on financial subjects here and on Barchart Portfolio Blogs and Seeking Alpha. He earned a BS in Accounting and Business Administration from Berry College; a Juris Doctorate from the Woodrow Wilson School of Law; and... More
My company:
Marketocracy capital management
My blog:
Barchart Portfolio Blogs
  • Newlinks Genetics - Barchart's Chart Of The Day 0 comments
    Feb 3, 2014 5:59 PM | about stocks: NLNK

    The Chart of the Day is Newlinks Genetics (NASDAQ:NLNK). I found the stock by using Barchart to sort the All Time New High List for frequency in the last month, then used the Flipchart feature to review the charts. Since the Trend Spotter signaled a buy on 1/7 the stock soared 56.89%.

    NLNK is a biopharmaceutical company which focuses on discovering, developing and commercializing immunotherapeutic products for cancer treatment. Its portfolio also includes biologic and small-molecule immunotherapy products used for the treatment of oncology indications.

    (click to enlarge)

    Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.

    Barchart technical indicators:

    • 96% Barchart technical buy signals
    • Trend Spotter buy signal
    • Above its 20, 50 and 100 day moving averages
    • 14 new highs and up 62.81% in the last month
    • Relative Strength Index 74.45%
    • Barchart computes a technical support level at 34.13
    • Recently traded at 35.85 with a 50 day moving average of 25.26

    Fundamental factors:


    • Market Cap $921.35 million
    • Revenue expected to decrease 34.20% this year then increase by 26.10% next year
    • Earnings are estimated to decrease by 15.20% this year and another 30.20% next year
    • In spite of those consensus forecasts Wall Street analysts issued 4 strong buy and 2 buy recommendation
    • Financial strength is B

    I would not buy into any stock that is increasing in price despite forecasts of decreasing revenue and earnings. If you already own it watch the 50 day moving average for signs of weakness and use the 100 day moving average as an exit point.

    Stocks: NLNK
Back To Jim Van Meerten's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


  • $HTBK - 96% technical buy signals - 20 new highs and up 12.40% in the last month - Relative Strength Index 73.83%
    about 2 hours ago
  • $AVGO - 96% technical buy signals - 11 new highs and up 10.15% in the last month - Relative Strength Index 65.65%
    4 days ago
  • $ULTA - 96% technical buy signals - 11 new highs and up 5.76% in the last month - Relative Strength 69.50%
    4 days ago
More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.